Bilateral Malignant Pleural Effusions in Lymphoma

Epidemiology

Lymphoma presents with bilateral effusions in a minority of cases, with the mechanism in Hodgkin's disease typically being obstruction of lymphatic drainage by enlarged mediastinal lymph nodes, and in non-Hodgkin's lymphoma being direct tumor infiltration of the pleura 1, 2, 3
Lymphoma accounts for approximately 10% of all malignant pleural effusions overall 1, 2, 3, 4, 5
Breast carcinoma demonstrates a notably higher rate of bilateral involvement: in 99 patients with unilateral breast tumors and pleural effusions, 10% were bilateral, with 50% ipsilateral and 40% contralateral 2, 3

Heart failure remains the leading cause of bilateral effusions, accounting for more than 80% of transudative effusions and representing the most common etiology of bilateral presentations 5
Malignancy accounts for 26% of all pleural effusions, with lung cancer being the most common neoplasm, followed by breast cancer 5
Lymphoma should be considered in the differential but is not statistically more likely to present bilaterally than other malignancies 4, 5

Cytologic yield in lymphoma is relatively low (31-55%), with the lowest yield in Hodgkin's disease 1, 2, 3, 4
Thoracoscopy achieves superior diagnostic yield, with chromosome analysis showing approximately 85% sensitivity 1, 2, 4
Flow cytometry can demonstrate clonality and should be performed when lymphoma is suspected 1, 2

Average survival time after first thoracentesis in lymphoma with pleural effusion is short, approximately 6-7 months 2